BioInsight
An AI research companion for life-science teams that interprets spectroscopy and structural-biology data, picks the right statistical tests, cross-checks results by independent methods, and produces publication-ready figures.
bench scientists at small biotech startups and academic labs
- Interprets NMR, mass-spec, and Cryo-EM outputs with explicit confidence levels
- Suggests statistical tests and flags confounders before the user runs them
- Cross-validates results by running two independent analysis methods automatically
- Generates publication-ready figures, captions, and methods paragraphs
Opus 5 posts a 10.2-point lift on organic-chemistry spectroscopy tasks and a 7.7-point lift on protein-function prediction versus Opus 4.8, finally making a wet-lab-grade copilot plausible.
Multiple established and well-funded tools (BenchSci, Bruker/NMRtist, Sapiosciences) plus OpenAI's LifeSciBench taxonomy (evidence handling, analysis, design) confirm real workflows; HN front-page discussion of Opus 5 (1211 pts) and Anthropic/Vellum reporting concrete 10.2-pt / 7.7-pt spectroscopy & protein-function lifts indicate strong interest.Introducing LifeSciBench - OpenAI ↗Claude Opus 5 Benchmarks Explained - vellum.ai ↗
Crowded: BenchSci just partnered with Thermo Fisher (Sep 2025), Bruker ships NMRtist for automated protein NMR, Schrödinger/Prism dominate structural biology, Benchling owns the lab-notebook layer, and OpenAI/Anthropic themselves ship the underlying reasoning — bundling the full 'interpret+stats+cross-check+figures' workflow into one product is the differentiator, not any single piece.BenchSci Announces Strategic Partnership with Thermo Fisher Scientific ↗NMRtist - Bruker ↗
Real budget exists — kriraai's small-biotech adoption guide cites $15K-$40K/yr per 10–50-person team for AI tools, and BenchSci raised a Thermo Fisher partnership — but small biotechs and academic labs are price-sensitive and the value must be defended against just using Claude/ChatGPT directly.AI Tools for Small Biotech Companies: Adoption Guide ↗Biotech AI Budget Benchmarks 2026: Mid-Market Spending Data ↗
Spectroscopy, structural-biology and statistics workflows are durable scientific infrastructure and Opus-class models keep improving the underlying capability, but the model layer itself is commoditizing fast, so differentiation must come from validated domain workflows and instrument-data integrations rather than raw model access.Introducing Claude Opus 5 | Anthropic ↗
Genuinely hard to build 'wet-lab-grade': requires ingesting heterogeneous instrument formats (NMR FID, MS, cryo-EM maps, X-ray), correct statistical methodology per assay, cross-validation against ground-truth datasets, and publication-grade matplotlib/PyMOL/ChimeraX figure output — domain expertise and validation alone are a multi-year effort.Biomolecular NMR spectroscopy in the era of artificial intelligence ↗